Editorial

Published on 22 Jun 2023

Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC

in Thoracic Oncology

Umberto Malapelle
Fabrizio Tabbò
Lucia Anna Muscarella

Frontiers in Oncology

doi 10.3389/fonc.2023.1239304

778 views
1 citation

Original Research

Published on 20 Jun 2023

Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase inhibitor treatment

in Thoracic Oncology

Cheng-Yu Chang
Chung-Yu Chen
Shih-Chieh Chang
Ching-Yi Chen
Yi-Chun Lai
Chun-Fu Chang
Yu-Feng Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1104098

2,185 views

Systematic Review

Published on 20 Jun 2023

Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports

in Thoracic Oncology

Liang Shi
Shuhong Gao
Li Tong
Qiyi Meng
Shijie Zhou
Daping Yu
Yujie Dong
Zhe Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1120511

2,159 views
3 citations

Original Research

Published on 19 Jun 2023

Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer

in Thoracic Oncology

Veronika Pelicon
Tanja Cufer
Lea Knez

Frontiers in Oncology

doi 10.3389/fonc.2023.1182748

4,138 views
4 citations

Original Research

Published on 16 Jun 2023

Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer

in Thoracic Oncology

Helen F. Titmarsh
Alex von Kriegsheim
Jimi C. Wills
Richard A. O’Connor
Kevin Dhaliwal
Margaret C. Frame
Samuel B. Pattle
David A. Dorward
Adam Byron
Ahsan R. Akram

Frontiers in Oncology

doi 10.3389/fonc.2023.1194515

2,697 views
5 citations

Editorial

Published on 16 Jun 2023

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer

in Thoracic Oncology

Qinglin Shen
Ling Peng
Yi Zhang
Ruoxiang Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1234727

962 views

Original Research

Published on 15 Jun 2023

A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study

in Thoracic Oncology

Salvador Fudio
Laura Pérez-Ramos
Eduardo Asín-Prieto
Ali Zeaiter
Rubin Lubomirov

Frontiers in Oncology

doi 10.3389/fonc.2023.1152371

2,177 views
1 citation

Correction

Published on 14 Jun 2023

Corrigendum: Efficacy of modified thoraco-laparoscopic Ivor-Lewis versus traditional thoraco-laparoscopic Ivor-Lewis for esophageal cancer: propensity score-matched analysis

in Thoracic Oncology

Ziqiang Hong
Wenxi Gou
Yingjie Lu
Xusheng Wu
Yannan Sheng
Baiqiang Cui
Xiangdou Bai
Dacheng Jin
Yunjiu Gou

Frontiers in Oncology

doi 10.3389/fonc.2023.1216836

836 views

Perspective

Published on 14 Jun 2023

Addressing the unmet need for a comprehensive lung cancer registry in Romania

in Thoracic Oncology

Gheorghe-Emilian Olteanu
Cristian Iulian Oancea
Marian Catalin
Adrian Pavel Trifa
Stefan Dascalu

Frontiers in Oncology

doi 10.3389/fonc.2023.1211533

2,374 views
1 citation

Original Research

Published on 12 Jun 2023

Prediction of distant organ metastasis and overall survival of lung cancer patients: a SEER population−based cohort study

in Thoracic Oncology

Yongping Hao
Guang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1075385

3,124 views
3 citations

Original Research

Published on 09 Jun 2023

Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study

in Thoracic Oncology

Jianghua Ding
Zhaohui Leng
Hong Gu
Xiang Jing
Yun Song

Frontiers in Oncology

doi 10.3389/fonc.2023.1153131

1,684 views
4 citations

Original Research

Published on 08 Jun 2023

A nomogram combining thoracic CT and tumor markers to predict the malignant grade of pulmonary nodules ≤3 cm in diameter

in Thoracic Oncology

Jianhao Qiu
Rongyang Li
Yukai Wang
Xiuyuan Ma
Chenghao Qu
Binyan Liu
Weiming Yue
Hui Tian

Frontiers in Oncology

doi 10.3389/fonc.2023.1196883

1,671 views

Editorial

Published on 07 Jun 2023

Editorial: Overcoming drug relapse and therapy resistance in NSCLC

in Thoracic Oncology

Sagun Parakh
Tracy L. Leong
Sarah A. Best
Ashleigh R. Poh

Frontiers in Oncology

doi 10.3389/fonc.2023.1230475

1,255 views
1 citation

Original Research

Published on 05 Jun 2023

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study

in Thoracic Oncology

Ningning Li
Liwei Gao
Chunmei Bai
Lin Zhao
Yajuan Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1167213

1,290 views
2 citations

Brief Research Report

Published on 02 Jun 2023

Diagnosis of primary lung cancer and benign pulmonary nodules: a comparison of the breath test and 18F-FDG PET-CT

in Thoracic Oncology

Xiangxiang Ding
Guihu Lin
Peiyu Wang
Haibin Chen
Nan Li
Zhi Yang
Mantang Qiu

Frontiers in Oncology

doi 10.3389/fonc.2023.1204435

2,108 views
3 citations

Original Research

Published on 31 May 2023

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

in Thoracic Oncology

Reem Altaf
Umair Ilyas
Anmei Ma
Meiqi Shi

Frontiers in Oncology

doi 10.3389/fonc.2023.1206768

3,668 views
3 citations

Navigation group

Articles

Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC

Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase inhibitor treatment

Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports

Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer

Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer

A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study

Corrigendum: Efficacy of modified thoraco-laparoscopic Ivor-Lewis versus traditional thoraco-laparoscopic Ivor-Lewis for esophageal cancer: propensity score-matched analysis

Addressing the unmet need for a comprehensive lung cancer registry in Romania

Prediction of distant organ metastasis and overall survival of lung cancer patients: a SEER population−based cohort study

Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study

A nomogram combining thoracic CT and tumor markers to predict the malignant grade of pulmonary nodules ≤3 cm in diameter

Editorial: Overcoming drug relapse and therapy resistance in NSCLC

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study

Diagnosis of primary lung cancer and benign pulmonary nodules: a comparison of the breath test and 18F-FDG PET-CT

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis